Intestinal Necrosis: Causes, Symptoms, and Treatment

Intestinal necrosis is the death of tissue in part of the gut, almost always triggered by a critical loss of blood flow. It sits at the end stage of a process called mesenteric ischemia, and without rapid treatment, mortality hovers around 50 percent.¹ The condition is uncommon but disproportionately deadly, and the difference between a survivable episode and a fatal one usually comes down to how quickly the blood supply is restored or the dead bowel removed.

What Causes the Blood Supply to Fail

The intestines receive their blood through the mesenteric arteries and veins. Anything that blocks or severely reduces that flow can starve the bowel wall of oxygen and start a cascade toward tissue death. The major causes fall into a few categories, and arterial problems are far more common than venous ones.²

Arterial embolism: A blood clot forms elsewhere in the body, often in the heart during atrial fibrillation, and lodges in a mesenteric artery. This is the single most frequent trigger for acute mesenteric ischemia.³
Arterial thrombosis: A clot builds up at the site of an already narrowed artery, typically from long-standing atherosclerosis. The blockage tends to be more extensive than an embolism because the underlying vessel disease is widespread.
Venous thrombosis: A clot in the mesenteric veins backs up blood in the intestinal wall, causing swelling, congestion, and eventually ischemia. Risk factors include clotting disorders, liver disease, and recent abdominal surgery.
Nonocclusive ischemia: No physical blockage exists at all. Instead, the mesenteric arteries clamp down so severely that blood flow drops below what the gut needs. This happens during shock, heart failure, or any state of severe circulatory stress, where the body diverts blood away from the gut to protect the brain and heart.⁴
Strangulating obstruction: A section of bowel gets trapped and kinked, usually by adhesions from prior surgery, a hernia, or a twist (volvulus). The trapped loop’s blood supply is pinched off mechanically.⁵

In nonocclusive disease specifically, the mechanism is a kind of exaggerated survival response. The body shunts blood toward vital organs, and the gut absorbs the cost. That supply-demand mismatch worsens if abdominal pressure rises, if feeding continues while circulation is poor, or if certain vasopressor drugs further constrict the mesenteric vessels.⁴ Critically ill patients on life support are especially vulnerable to this form.

How Ischemia Progresses to Necrosis and Sepsis

When blood flow drops, the inner lining of the intestine is the first layer to suffer because it sits farthest from the arterial supply and has the highest metabolic demand. That lining normally acts as a barrier, keeping trillions of gut bacteria on the inside. As ischemia deepens, the barrier breaks down. Bacteria and their toxins cross into the bloodstream, a process called bacterial translocation, and can trigger a body-wide inflammatory response.⁶ This is the bridge between a localized bowel problem and life-threatening sepsis and organ failure.⁷

If blood flow is restored before the damage becomes full-thickness, the tissue can recover. But once the entire bowel wall dies, the damage is irreversible and that segment must be removed surgically. Making matters worse, restoring blood flow itself causes a second wave of injury. Oxygen flooding back into oxygen-starved tissue generates a burst of damaging molecules. Research into drugs that could blunt this reperfusion injury is active but still largely experimental, with compounds targeting oxidative stress pathways showing promise in laboratory settings.⁸

Recognizing the Symptoms

The classic presentation of acute mesenteric ischemia is severe abdominal pain that seems wildly out of proportion to what a doctor can find on physical exam. Early on, the abdomen may be soft and not particularly tender to the touch, even though the patient is in agony. That disconnect is one of the most important clinical clues.

As the condition progresses and tissue begins to die, the picture changes. The abdomen becomes rigid and distended. Nausea, vomiting, and bloody stools may develop. Heart rate climbs, blood pressure drops, and signs of septic shock set in. A case report of a 56-year-old man with intestinal necrosis complicated by septic shock illustrates how rapidly things can deteriorate: by the time he reached the operating room his heart rate was 130, his blood pressure had crashed, and his oxygen levels were dangerously low.⁹

Part of what makes this condition so lethal is that the initial symptoms overlap with dozens of less serious problems. Acute mesenteric ischemia is uncommon, accounting for a fraction of a percent of acute surgical admissions, and it almost always occurs in patients who already have other health problems.¹ It is easy for the diagnosis to be delayed while more common conditions are considered first.

How Intestinal Necrosis Is Diagnosed

The workhorse of diagnosis is CT angiography, a contrast-enhanced scan that can show both the blood vessels feeding the gut and the bowel wall itself. A systematic review and meta-analysis found CT angiography had a sensitivity of about 92% and specificity of roughly 99% for acute mesenteric ischemia, meaning it catches the vast majority of cases and very rarely calls it when it is not there.¹⁰ Standard CT scans without the dedicated vascular protocol are considerably less accurate.¹¹

Specific scan findings help distinguish partial ischemia from full-thickness necrosis. Gas bubbles within the bowel wall, known as pneumatosis, and gas in the portal veins are ominous signs pointing toward tissue death. These findings are more common in nonocclusive disease than in cases caused by a physical blockage or bowel strangulation.¹² A bowel wall that fails to take up contrast dye, or one that looks thinned and paper-like, also signals necrosis. In strangulated bowel obstruction, the wall tends to show the opposite pattern, appearing denser than normal on an unenhanced scan because of hemorrhage into the tissue.¹³

The Search for a Blood Test

No single blood test reliably diagnoses mesenteric ischemia early enough to prevent necrosis, and this remains one of the biggest frustrations in the field.¹⁴ Elevated lactate, a common marker of tissue oxygen deprivation, is nonspecific since many critical illnesses raise lactate. D-dimer is sensitive but similarly vague. The most promising candidate is intestinal fatty acid-binding protein (I-FABP), a molecule released specifically when the intestinal lining is damaged. In experimental work, I-FABP levels rose within 30 minutes of ischemia, even before visible tissue changes appeared.¹⁵ In human studies, I-FABP sensitivity has ranged anywhere from about 62% to 100% depending on the threshold used and the population studied.¹⁶ That wide range reflects the reality that the test is not yet ready for routine clinical use, but it points a direction for future development.

Treatment When Necrosis Has Set In

Once bowel tissue has died, surgery to remove the necrotic segment is unavoidable. No drug can reverse full-thickness necrosis. The goals of the initial operation are to remove clearly dead bowel, restore blood flow when possible, and preserve as much healthy intestine as the surgeon safely can. That last goal is critical because the more bowel removed, the greater the risk of devastating nutritional consequences afterward.

The problem is that at the time of the first operation, it is often impossible to tell exactly which segments are dying and which will recover. Bowel that looks questionable during surgery may go on to survive, or it may continue to deteriorate after the abdomen is closed.¹⁷ For this reason, a planned second operation, typically 24 to 96 hours later, is a cornerstone of management. The surgeon reopens the abdomen, reassesses the bowel, removes any newly necrotic segments, and reconnects the remaining intestine.¹⁸ In neonates with severe necrotizing enterocolitis, a similar staged approach uses what is sometimes called a damage-control laparotomy: dead bowel is removed and the cut ends are temporarily tied off, giving the tissue a few days to fully declare itself before final reconnection.¹⁹

Judging Bowel Viability in the Operating Room

Traditionally, surgeons assess bowel viability by looking at its color, feeling for a pulse in the feeding vessels, and watching for visible contractions. These methods are subjective and imperfect. A newer approach uses a dye called indocyanine green, injected into a vein, which lights up under near-infrared light wherever blood is flowing. It gives real-time, visual confirmation of perfusion in the bowel wall and can help surgeons avoid removing segments that still have a viable blood supply.²⁰ In pediatric cases, the same technique has been used to guide resection decisions in children with intestinal volvulus.²¹

Indocyanine green fluorescence is not foolproof, though. When the bowel wall is swollen and edematous, the dye signal can be muted, giving a falsely gloomy picture. Combining it with Doppler ultrasound to check for arterial flow in the vessel wall has helped resolve ambiguous cases. In a small series, this combination approach spared bowel that a single technique alone would have flagged for removal.²²

Endovascular Versus Open Surgery for Restoring Blood Flow

When the cause is an arterial blockage, restoring flow is as important as removing dead tissue. There are two broad approaches: open surgery, where the abdomen is opened and the blocked artery is physically cleared or bypassed, and endovascular therapy, where catheters threaded through the groin break up or stent the clot from inside the vessel.

A systematic review comparing the two found that endovascular-first approaches were associated with lower rates of bowel resection and a reduced risk of short bowel syndrome, with hospital stays tending to be shorter.²³ However, short-term mortality was statistically similar between the two strategies, and endovascular patients were more likely to need repeat procedures.²⁴ A large Japanese database study confirmed comparable in-hospital mortality between the two approaches while noting that endovascular patients had shorter stays and lower costs.²⁵

The consensus emerging from the evidence is that endovascular therapy works best for patients who do not yet have signs of bowel necrosis at the time of presentation. Once the gut has clearly died, open surgery is generally still needed because the dead tissue must be physically removed. Endovascular clot removal alone cannot fix what has already been destroyed.

Life After Massive Bowel Resection

Surviving intestinal necrosis is only the beginning of a long road for patients who lose a large portion of their intestine. When less than roughly 200 centimeters of small bowel remains, the body can no longer absorb enough nutrients from food, a condition called short bowel syndrome.²⁶ It is life-altering and can be life-threatening, requiring long-term intravenous nutrition to prevent malnutrition and dehydration.²⁷

Some patients eventually wean off intravenous feeding as their remaining intestine adapts, growing new absorptive surface over months to years. For those who cannot tolerate long-term intravenous nutrition, intestinal transplantation is an option, though outcomes remain poor compared to transplants of other organs.²⁸ The practical reality is that many survivors live with some degree of chronic diarrhea, nutrient deficiencies, and dependence on specialized nutritional support for the rest of their lives. This is why preserving every centimeter of viable bowel during surgery matters so much.

Chronic Mesenteric Ischemia as a Warning Sign

Not all intestinal ischemia arrives as a sudden emergency. Some patients develop chronic mesenteric ischemia, a slow narrowing of the mesenteric arteries from atherosclerosis that produces cramping abdominal pain after eating, unintentional weight loss, and a growing fear of food. The condition is uncommon but clinically important because, left untreated, it can suddenly convert into an acute event with full-blown bowel necrosis.²⁹

Revascularization, whether through open surgery or a stent placed via catheter, can relieve symptoms, restore normal eating, and prevent that catastrophic progression to infarction.³⁰ Patients with the classic triad of postprandial pain, weight loss, and known vascular disease should be evaluated before an acute crisis develops. The chronic form accounts for a small minority of all mesenteric ischemia cases, but catching it early is one of the few opportunities to intervene before tissue is lost.

Necrotizing Enterocolitis in Premature Infants

In neonatal intensive care units, intestinal necrosis takes a different form. Necrotizing enterocolitis, known as NEC, is the most common gastrointestinal emergency in premature infants. Its exact cause is not fully understood, but the two most consistent risk factors are prematurity and formula feeding.³¹ The immature gut lining, an unstable blood supply, and an underdeveloped immune system all appear to set the stage for a runaway inflammatory response that can destroy segments of intestine within hours.

Prevention strategies that have shown benefit include breast milk feeding, standardized feeding guidelines that advance volumes slowly, and probiotics. When NEC progresses to perforation or full-thickness necrosis, surgical removal of the dead bowel is necessary, and the staged surgical approach described earlier was developed largely for these tiny patients. Surviving infants face the same long-term risks of short bowel syndrome as adults, compounded by the nutritional demands of growth and development.

Drug-Induced Intestinal Ischemia

Certain medications can push the gut’s blood supply past its limits, especially in patients who already have compromised circulation. Vasopressors used in intensive care units are the most common culprits in the nonocclusive category, but individual drugs have also been linked to intestinal necrosis in case reports. Terlipressin, a vasopressin-related drug used to treat bleeding from esophageal varices and hepatorenal syndrome, acts primarily on the blood vessels supplying the gut. While it causes serious ischemic complications less often than older vasopressin formulations, cases of severe bowel necrosis during terlipressin therapy have been documented.³²

Cocaine is another well-recognized cause. It triggers intense vasoconstriction throughout the body, and the mesenteric arteries are vulnerable targets. Ergot-derived medications, some migraine drugs, and digitalis in toxic doses have also been implicated. The practical point is that drug-induced mesenteric ischemia can mimic every other form of the condition, and a medication history is a crucial part of the diagnostic workup. In some cases, stopping the offending drug and supporting blood pressure is enough to reverse ischemia before necrosis develops.

Who Is Most at Risk

Intestinal necrosis from mesenteric ischemia overwhelmingly affects older adults with cardiovascular disease. Atrial fibrillation is a major risk factor for arterial embolism. Atherosclerosis sets the stage for both arterial thrombosis and chronic mesenteric ischemia. Heart failure and recent cardiac surgery increase the risk of nonocclusive disease. Conditions that promote blood clotting, such as inherited thrombophilia or cancer, raise the risk of venous thrombosis in the mesenteric veins.

At the other end of the age spectrum, premature infants face necrotizing enterocolitis, as described above. Between these extremes, younger adults can develop intestinal necrosis from strangulated hernias, volvulus, or drug-related causes, but this is comparatively rare. The incidence of acute mesenteric ischemia across all ages is estimated at roughly 0.09 to 0.2% of acute surgical admissions, but it rises sharply with age.¹ As populations age and more people live with atrial fibrillation and vascular disease, clinicians expect the absolute number of cases to grow even if the rate per admission stays flat.

1
BioMed Central / World Journal of Emergency Surgery. Acute mesenteric ischemia: updated guidelines of the World Society of Emergency Surgery
2
PubMed. Acute Mesenteric Ischemia: Multidetector CT Findings and Endovascular Management
3
PubMed Central. Acute mesenteric ischaemia: a pictorial review
4
PubMed. The Pathogenesis of Nonocclusive Mesenteric Ischemia: Implications for Research and Clinical Practice
5
PubMed. CT diagnosis of acute mesenteric ischemia from various causes
6
PubMed Central. The role of bacterial translocation in sepsis: a new target for therapy
7
Frontiers in Immunology. Challenge to the Intestinal Mucosa During Sepsis
8
International Journal of Biological Sciences. Intestinal Ischemia/Reperfusion Injury: Mechanisms, Diagnosis, and Therapeutic Advances
9
Asploro Journal of Biomedical and Clinical Case Reports. Anesthetic Management of Intestinal Ischemic Necrosis Complicated by Septic Shock: A Case Report
10
PubMed Central. Radiological diagnosis of acute mesenteric ischemia in adult patients: a systematic review and meta-analysis
11
PubMed. CT angiography in the setting of suspected acute mesenteric ischemia: prevalence of ischemic and alternative diagnoses
12
American Roentgen Ray Society (AJR). Transmural Bowel Necrosis From Acute Mesenteric Ischemia and Strangulated Small-Bowel Obstruction: Distinctive CT Features
13
PubMed. Increased unenhanced bowel-wall attenuation: a specific sign of bowel necrosis in closed-loop small-bowel obstruction
14
PubMed Central. Biochemical markers of acute intestinal ischemia: possibilities and limitations
15
PLOS ONE. I-FABP as Biomarker for the Early Diagnosis of Acute Mesenteric Ischemia and Resultant Lung Injury
16
PubMed Central. The Impact of Biomarkers on the Early Detection of Acute Mesenteric Ischemia
17
PubMed. Indications and procedures for second-look surgery in acute mesenteric ischemia
18
PubMed Central. Planned second-look laparoscopy in the management of acute mesenteric ischemia
19
PubMed. Damage control laparotomy for generalized necrotizing enterocolitis
20
PubMed Central. Intraoperative real-time fluorescence angiography with indocyanine green for evaluation of intestinal viability during surgery for an incarcerated obturator hernia: a case report
21
Journal of Pediatric Surgery Case Reports. Predicting viability of ischemic small bowel using intraoperative indocyanine green fluorescence angiography
22
PubMed. Intraoperative Assessment of Bowel Viability Using Indocyanine Green Fluorescence and Doppler Ultrasound in Incarcerated or Threatened Bowel Obstruction
23
PubMed. Endovascular revascularization vs open surgical revascularization as the first strategy for arterial acute mesenteric ischemia: A systematic review and meta-analysis
24
PubMed Central. Endovascular Versus Open Surgical Approaches for Acute Mesenteric Ischemia: A Systematic Review of Outcomes
25
PubMed Central. Comparison of Endovascular Therapy and Open Surgical Revascularization in Patients With Acute Superior Mesenteric Artery Occlusion: A Large-Scale Analysis Based on the JROAD-DPC Database
26
PubMed. Short bowel syndrome
27
PubMed Central. Short Bowel Syndrome
28
PubMed. Short bowel syndrome in children and adults: from rehabilitation to transplantation
29
PubMed Central. Chronic mesenteric ischemia: diagnosis and treatment
30
Progress in Cardiovascular Diseases. Chronic mesenteric ischemia: Diagnosis and management
31
PubMed Central. Necrotizing enterocolitis risk: state of the science
32
PubMed Central. Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome